A new study published May 31 in the Journal of Clinical Oncology
reports that beta-blocker use is associated with improved relapse-free
survival in all patients with breast cancer, including those with
triple-negative breast cancer (TNBC), a particularly aggressive form
of the disease.
Previous epidemiological research has shown that breast cancer is
potentially more likely to recur in the context of chronic stress and